Category: Medicare

Podcast: KHN’s ‘What The Health?’ Health Nerd Books For The Holidays

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Stephanie Armour of The Wall Street Journal, Joanne Kenen of Politico and Anna Edney of Bloomberg News discuss the latest on open enrollment for the Affordable Care Act and Medicare; new moves by the Food and Drug Administration to regulate tobacco and nicotine products; and whether House Democrats will pursue a “Medicare-for-all” bill in the next Congress. Plus, for extra credit, the panelists recommend their favorite health policy books for your holiday reading and gifting pleasure.

Trumpeted New Medicare Advantage Benefits Will Be Hard For Seniors To Find

Federal officials are hailing the introduction of services such as transportation to medical appointments, home-delivered meals and installation of wheelchair ramps as a way to keep beneficiaries healthy and avoid costly hospitalizations. But not many plans are offering the services in 2019.

The New Health Care Agenda: Gridlock, Lots of Hearings

In an Axios column, Drew Altman analyzes what the midterm election means for the health policy agenda between now and 2020–mostly political positioning and gridlock in Congress, with most of the action affecting people in the states. 

Midterm Results Show Health Is Important To Voters But No Magic Bullet

Even though they are taking control of the House, Democrats will be unlikely to advance many initiatives on health that don’t meet Republican approval since the GOP controls the Senate and the White House. But they can block any efforts to weaken the Affordable Care Act or change Medicaid or Medicare.

The conservative appeal of Medicare for all

Everyone thinks of “Medicare for all” as a liberal idea, an extremely liberal one embraced by the socialist wing of the Democratic Party. It’s an idea Democrats were hesitant to embrace in the Obama era, for being too far out of mains…

Dialysis Giant DaVita Defends Itself In Court And At The Polls

Although dialysis provider DaVita Inc. has taken major financial hits this year, including a $383.5 million jury award in response to wrongful death lawsuits, it still rakes in profits. The company faces its biggest threat next month, when California voters weigh in on a ballot initiative that could force it to leave the state.

Trump Adds A Global Pricing Plan To Wide Attack On Drug Prices, But Doubts Persist

Over the past five months, the Trump administration has proposed a series of reforms to lower the cost of prescription drugs.

Podcast: KHN’s ‘What The Health?’ Trump, GOP Fight Back On Health Care

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Kimberly Leonard of the Washington Examiner and Alice Ollstein of Politico discuss a flurry of proposals from the Trump administration on prices Medicare pays for drugs and the Affordable Care Act.

Politicians Hop Aboard ‘Medicare-For-All’ Train, Destination Unknown

Candidates are charging toward midterm elections on a platform of single-payer and universal coverage rhetoric. Yet “Medicare-for-all” and single-payer mean different things to different people.

Podcast: KHN’s ‘What The Health?’ Republicans’ Preexisting Political Problem

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Rebecca Adams of CQ Roll Call, Stephanie Armour of The Wall Street Journal and Joanne Kenen of Politico discuss how protections for people with preexisting conditions have become a top issue in the elections, Trump administration efforts to make prescription drug prices more public and the start of Medicare’s annual open-enrollment period. Plus, Rovner interviews California Attorney General Xavier Becerra.